Skip to main content
Log in

Should we use anticoagulation for patients with chronic heart failure?

  • Viewpoint
  • Published:

From Nature Clinical Practice Cardiovascular Medicine

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kannel WB et al. (1983) Manifestations of coronary disease predisposing to stroke: the Framingham study. JAMA 250: 2942–2946

    Article  CAS  Google Scholar 

  2. Freudenberger RS et al.: The incidence of thromboembolism in patients with NYHA class II and III heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). J Am Coll Cardiol, in press

  3. Dunkman WB et al. (1993) Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 87 (Suppl 6): SVI94–SVI101

    Google Scholar 

  4. Loh E et al. (1997) Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 336: 251–257

    Article  CAS  Google Scholar 

  5. Dries DL et al. (1997) Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 29: 1074–1080

    Article  CAS  Google Scholar 

  6. Baker DW and Wright RF (1994) Management of heart failure IV: anticoagulation for patients with heart failure due to left ventricular systolic dysfunction. JAMA 272: 1614–1618

    Article  CAS  Google Scholar 

  7. Freudenberger RS and Fuster V (1996) Fifty years of experience with antithrombotic therapy in cardiac disease: a 1996 approach based on pathogenesis and risk. Mt Sinai J Med 63: 342–358

    CAS  PubMed  Google Scholar 

  8. Antiplatelet Trialists' Collaboration. (1994) Collaborative overview of randomised trials of antiplatelet therapy–I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308: 81–106

  9. Al-Khadra AS et al. (1998) Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Trial. J Am Coll Cardiol 31: 419–425

    Article  CAS  Google Scholar 

  10. Leor J et al. (1999) Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 33: 1920–1925

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ronald S Freudenberger.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Freudenberger, R., Halperin, J. Should we use anticoagulation for patients with chronic heart failure?. Nat Rev Cardiol 3, 580–581 (2006). https://doi.org/10.1038/ncpcardio0688

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0688

  • Springer Nature Limited

Navigation